Affluent Medical announces today the positive conclusion of its OPTIMISE first clinical study for KALIOS, its adjustable mitral repair device. KALIOS has been implanted in five patients between January and May of the current year by Prof. Martin Andreas, Principal Investigator of this feasibility study, at the Vienna General Hospital (AKH). The first results of the study show that the primary endpoint has been attained, proving the surgical safety of KALIOS.
04 / 09 / 18
Affluent Medical announces the successful conclusion of its OPTIMISE clinical study for KALIOS